Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Lazo-Langner

Showing results (11-20 of 135) with videos related to

Pageof 14
Sort By:
Blood|February 28, 2014
Acute myeloid leukemia relapse first presenting in the cerebrospinal fluidCyrus C Hsia, Alejandro Lazo-Langner
Clinical Advances in Hematology & Oncology : H&O|February 24, 2006
Standard-intensity vs low-dose anticoagulation for long-term management of patients with venous thromboembolismAlejandro Lazo-Langner, Michael J Kovacs
Blood|December 12, 2012
Histoplasmosis-induced pancytopeniaCyrus C Hsia, Alejandro Lazo-Langner
Minerva Medica|May 5, 2021
Treatment of retinal vein thrombosis: what about anticoagulants?Omar M Raslan, Alejandro Lazo-Langner
Journal of Thrombosis and Haemostasis : JTH|July 30, 2021
APTT therapeutic range for monitoring unfractionated heparin therapy. Significant impact of the anti-Xa reagent used for correlation: COMMENTMichael J Kovacs, Alejandro Lazo-Langner
The Orthopedic Clinics of North America|July 7, 2009
Overview of current venous thromboembolism protocols in hip reconstructionAlejandro Lazo-Langner, Marc A Rodger
Current Opinion in Pulmonary Medicine|May 18, 2010
Predicting warfarin doseAlejandro Lazo-Langner, Michael J Kovacs
Hepatobiliary Surgery and Nutrition|May 18, 2019
Long term follow-up after liver transplantation from a <i>JAK2</i> mutation positive donorAlejandro Lazo-Langner, Peter Ainsworth, Vivian McAlister
The New England Journal of Medicine|March 11, 2011
Retinal-vein occlusionAlejandro Lazo-Langner, Alessandro Squizzato, Walter Ageno
Hematology (Amsterdam, Netherlands)|January 10, 2016
Erythropoietin in anemia of unknown etiology: A systematic review and meta-analysisSwetha Sriram, Anargyros Xenocostas, Alejandro Lazo-Langner
Pageof 14

Showing results (11-20 of 135) with videos related to

Sort By:
Pageof 14
Blood|February 28, 2014
Acute myeloid leukemia relapse first presenting in the cerebrospinal fluidCyrus C Hsia, Alejandro Lazo-Langner
Clinical Advances in Hematology & Oncology : H&O|February 24, 2006
Standard-intensity vs low-dose anticoagulation for long-term management of patients with venous thromboembolismAlejandro Lazo-Langner, Michael J Kovacs
Blood|December 12, 2012
Histoplasmosis-induced pancytopeniaCyrus C Hsia, Alejandro Lazo-Langner
Minerva Medica|May 5, 2021
Treatment of retinal vein thrombosis: what about anticoagulants?Omar M Raslan, Alejandro Lazo-Langner
Journal of Thrombosis and Haemostasis : JTH|July 30, 2021
APTT therapeutic range for monitoring unfractionated heparin therapy. Significant impact of the anti-Xa reagent used for correlation: COMMENTMichael J Kovacs, Alejandro Lazo-Langner
The Orthopedic Clinics of North America|July 7, 2009
Overview of current venous thromboembolism protocols in hip reconstructionAlejandro Lazo-Langner, Marc A Rodger
Current Opinion in Pulmonary Medicine|May 18, 2010
Predicting warfarin doseAlejandro Lazo-Langner, Michael J Kovacs
Hepatobiliary Surgery and Nutrition|May 18, 2019
Long term follow-up after liver transplantation from a <i>JAK2</i> mutation positive donorAlejandro Lazo-Langner, Peter Ainsworth, Vivian McAlister
The New England Journal of Medicine|March 11, 2011
Retinal-vein occlusionAlejandro Lazo-Langner, Alessandro Squizzato, Walter Ageno
Hematology (Amsterdam, Netherlands)|January 10, 2016
Erythropoietin in anemia of unknown etiology: A systematic review and meta-analysisSwetha Sriram, Anargyros Xenocostas, Alejandro Lazo-Langner
Pageof 14